14 results · 40ms · Sources: EU EUDAMED, US FDA

Eosin B

FDA classification
FDA Class 1 ·Eosin B

Bag, Ice

FDA classification
FDA Class 1 ·Bag, Ice

Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

FDA classification
FDA Class 2 ·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

Pacemaker/Icd/Crt Non-Implanted Components

FDA classification
FDA Class 3 ·Pacemaker/Icd/Crt Non-Implanted Components

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

FDA classification
FDA Class 3 ·Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

Analyzer, Gas, Carbon-Dioxide, Partial Pressure, Blood-Phase, Indwelling

FDA classification
FDA Class 2 ·Analyzer, Gas, Carbon-Dioxide, Partial Pressure, Blood-Phase, Indwelling

Cresolphthalein Complexone, Calcium

FDA classification
FDA Class 2 ·Cresolphthalein Complexone, Calcium

Atrial Defibrillator

FDA classification
FDA Class 3 ·Atrial Defibrillator

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

FDA classification
FDA Class 3 ·Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

Neonatal Icu Continuous Non-Invasive Blood Pressure Monitor (Includes Alarms)

FDA classification
FDA Class 2 ·Neonatal Icu Continuous Non-Invasive Blood Pressure Monitor (Includes Alarms)

Permanent Defibrillator Electrodes

FDA classification
FDA Class 3 ·Permanent Defibrillator Electrodes

Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma

FDA classification
FDA Class 2 ·Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma

Endoscopic Magnetic Retriever, Exempt

FDA classification
FDA Class 2 ·Endoscopic Magnetic Retriever, Exempt

Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission

FDA classification
FDA Class 2 ·Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission